We screened 1166 studies on STD/HIV/UTI this month. These are the most important.
African-American MSM have 3-fold higher risk for young-onset prostate cancer
- Compared with non-African men who have sex with men, African American HIV-positive and HIV-negative men aged 40-55 y have 3-fold increased risk for young-onset prostate cancer.
HIV: targeted testing tops universal screening in young sexual minority males
- Compared with universal screening, community-based targeted approaches to HIV testing are more effective in reaching young sexual minority males (especially of color), identifying new HIV-positive youths, and linking HIV-negative youths to preventive services.
HIV PEP: once-daily dolutegravir + tenofovir/emtricitabine yields 90% completion rate
- Once-daily postexposure prophylaxis using dolutegravir with tenofovir disoproxil fumarate-emtricitabine appears safe and well-tolerated, with high adherence and completion rates in gay and bisexual men.
Other recent Vitals: